Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026)
Quanterix (QTRX) posted Asset Writedowns and Impairment of $305000.0 for Q1 2026, down 36.85% on a QoQ basis from $483000.0 in Q4 2025, and up 475.47% year-over-year from $53000.0 in Q1 2025.
Quanterix (QTRX) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
Quanterix's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $305000.0 for Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 475.47% year-over-year to $305000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 6965.0% YoY) and the FY2025 annual result came in at $7.8 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $305000.0 for Q1 2026 at Quanterix, down from $483000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $25.7 million in Q4 2022 and bottomed at -$676000.0 in Q3 2024.
- A 5-year average of $2.3 million and a median of $241500.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment surged 35304.11% — and 2024, when it plunged 989.47%.
- Quanterix's Asset Writedowns and Impairment stood at $25.7 million in 2022, then sank by 95.21% to $1.2 million in 2023, then sank by 154.91% to -$676000.0 in 2024, then soared by 171.45% to $483000.0 in 2025, then sank by 36.85% to $305000.0 in 2026.
- Business Quant data shows QTRX's Asset Writedowns and Impairment at $305000.0 in Q1 2026, $483000.0 in Q4 2025, and $900000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Quanterix | 172.41 Mn | 73.15 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Jun 30, 2025 | -315,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Sep 30, 2024 | -676,000.00 |
| Sep 30, 2024 | -676,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 76,000.00 |
| Sep 30, 2023 | 76,000.00 |